ANSM unveils temporary scientific committee on «implementation of medical cannabis trials in France».»
After ANSM's Temporary Specialized Scientific Committee (CSST) which validated the need to implement the Temporary Scientific Committee (CST) for the «implementation of medical cannabis trials in France».
Lasting 6 months, the CST will study the conditions for experimenting with therapeutic cannabis in France. Like we unveiled it 15 days ago, At least 3 topics will be on the agenda: product specifications, patient registers and training resources for healthcare staff.
According to the decision of ANSM, the STC will be composed of :
- Nicolas AUTHIER as Chairman of the CST. He already chaired the previous CSST on medical cannabis.
- Philippe ANDRIEUX, of the Principes Actifs association
- Nadine ATTAL, neurologist by training, pain specialist
- Lucas BEURTON-COURAUD, general practitioner in Finistère, France
- Pierre CHAMPY, Professor of Pharmacognosy
- Laure COPEL, oncologist and head of the Palliative Care Unit at the Diaconesses Croix Saint-Simon Hospital Group
- Patrick DAIME, general practitioner and representative of the Conseil National de l'Ordre des Médecins (Cnom)
- Carole DE MULATIER, Project Manager, Union pour la lutte contre la sclérose en plaques (UNISEP)
- Vera DINKELACKER, neurologist
- Samira DJEZZAR, hospital doctor and member of addictovigilance IDF
- Antoine DUPUIS, Professor of Pharmacy
- Yannick FRELAT, member of Epilepsie France
- Marie-Madeleine GILANTON, spokesperson for the 'Espoir (Im)patient' association, President of APAISER (Association Pour Aider et Informer les Syringoméliques Européens Réunis) and member of the Alliance Maladies Rares.
- René MAAREK, pharmacist, member of the Union des syndicats de pharmaciens d'officine (Upso)
- Alexandre MACIUK, Doctor of Pharmacy and Senior Lecturer
- Bertrand RAMBAUD, President, UFCM-I Care
- Catherine SEBIRE, Director, Association francophone pour vaincre les douleurs (AFVD)
- Melissa YELEHE, Doctor of Pharmacy at Nancy University Hospital
The schedule for CST meetings has not yet been announced.
-
Business3 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France4 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec2 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.4 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis in France4 weeks ago
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business4 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
CBD4 weeks ago
October 2026 CBD Highlights: 10 Strains and Hash to Discover from 5 French Producers


pilila
October 16, 2019 at 19 h 36 min
So let them experiment! What the hell! Mix twice rather than once! They don't have to rely on the thousands of favorable scientific studies, specifying doses and desirable distribution methods, which have been available for at least ten years on the Internet and in specialized scientific journals.
In any case, as we all know, France is a country of extraterrestrials who don't react at all like the Americans, Australians, Israelis and so on.
We need home-grown protocols!
We're not like everyone else all the same, just a little more stupid!!!!